LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX
Best Market – MRNTF), pioneering the transformation of spinal surgery
through Artificial Intelligence, predictive modeling and patient
specific implants with its UNiD ASI™ (Adaptive Spine Intelligence)
proprietary software platform, services and technologies, announced
today that it hosted the second edition of its annual Medicrea
Artificial Intelligence and Analytics (MAIA) Meeting in New York, NY,
USA from April 26-27.
The MAIA group is an ongoing collaboration between surgeons and industry
that is the first of its kind to focus on the role of Artificial
Intelligence in the treatment of complex spinal deformities. During this
second edition, the company also demonstrated the advancements made to
its proprietary UNiD ASI™ (Adaptive Spine Intelligence) technology.
Since the FDA clearance of UNiD™ rods in November 2014 followed by the
FDA clearance of Medicrea’s proprietary digital platform in May 2017, a
tool based on Artificial Intelligence with the goal to assist surgeons
in building precise surgical planning in order to help them improve
their patient’s outcomes, 3700 patients have benefited from this unique
technology and have received UNID Patient Specific Rods.
“Medicrea just concluded a highly successful and educational meeting in
New York”, stated Dr Chris Ames, MD, Director of spinal tumor and spinal
deformity surgery at UCSF Medical Center, CA. “Participants heard
thought leading presentations and took part in stimulating round-tables
focused on new AI based technics and methods applied to spine care”.
MAIA was chaired by renowned surgeons in spine surgery, including Dr
Chris Ames, MD; Dr Vedat Deviren, MD, Professor of Orthoepedic Surgery
at the UCSF Spine Center, CA; and co-chaired by Dr Evalina Burger, MD,
Professor and Vice Chair of Orthopedics at the University of Colorado.
The faculty also featured 3 additional leaders, including Dr Rajiv
Sethi, MD, Spinal Surgeon, Neuroscience Institute, and Medical Director,
Neuroscience Institute at Virginia Mason, WA; Dr Themi Protopsaltis,
Chief, Division of Spine Surgery, Department of Orthopedic Surgery at
NYU Langone, NY; and Dr Han Jo Kim, Associate Attending Orthopedic
Surgeon, Hospital for Special Surgery, NY.
Dr Vijay Yanamadala, MD, Assistant Professor of Neurosurgery at Albert
Einstein College of Medicine, NY said “I was really impressed by how far
Medicrea has already come regarding application of artificial
intelligence to spine. They’ve developed an A.I. platform accessible
through a user-friendly interface called the UNiD HUB. The system
digests scientific data to generate intelligent surgical planning
through machine learning while simultaneously allowing you to perform
detailed, custom analyses of your cases and manage the entire workflow
from start to finish. Not only does it change the clinical
workflow, it makes it more efficient and increase productivity.”
During this course, Medicrea also shared follow up data regarding rod
breakage incidence. By
simulating surgical strategies using proprietary data and algorithms
taking into consideration patients’ optimal sagittal alignment and
compensatory mechanisms, Medicrea produces a patient-specific rod
industrially pre-bent to precisely match the optimal individual surgical
simulation. This process preserves the rod’s full integrity, and limits
stress points that could lead to rod fracture once implanted into the
“Medicrea is the first spine company to make custom rods for precise
correction of spinal deformity. The company’s R&D efforts have leveraged
its intelligent pre-operative surgical planning to become the only
manufacturer able to streamline inventory required for a surgery as well
as provide patient-specific devices. I can only wonder what they will
come with next” stated Dr Jad Khalil, MD, attending spine surgeon at
William Beaumont Hospital in Royal Oak, MI.
“Medicrea is proud to have welcomed some of the world’s most prestigious
spine surgeons to its second annual MAIA.” said Denys Sournac, Chief
Executive Officer of Medicrea. He also added “The first 2019 quarter has
seen a 68% growth of the artificial intelligence-based surgeries using
the UNiD ASI™ technology in the US. We are on the path to change the
standard of care for spine patients and we are excited to work with this
amazing group of surgeons to bring our spine A.I- based solutions to the
rest of the world.”.
About MEDICREA® (www.medicrea.com)
Through the lens of predictive medicine, MEDICREA® leverages its
proprietary software analysis tools with big data and machine learning
technologies supported by an expansive collection of clinical and
scientific data. The Company is well-placed to streamline the efficiency
of spinal care, reduce procedural complications and limit time spent in
the operating room.
Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium
sized Enterprise (SME) with 200 employees worldwide, which includes 50
who are based in the U.S. The Company has an ultra-modern manufacturing
facility in Lyon, France housing the development and production of 3D-
printed titanium patient-specific implants.
For further information, please visit: medicrea.com.
Connect with MEDICREA®
MEDICREA® is listed on
EURONEXT Growth Paris
ISIN: FR 0004178572
MEDICREA® is traded on
OTCQX Best Market
Founder, Chairman and CEO
Chief Financial Officer
+33 (0)4 72 01 87 87